Literature DB >> 7563174

Inhibition of mammary carcinogenesis in rats by sulfone metabolite of sulindac.

H J Thompson1, S Briggs, N S Paranka, G A Piazza, K Brendel, P H Gross, G J Sperl, R Pamukcu, D J Ahnen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7563174

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  13 in total

Review 1.  Biology, pathology, and therapeutic targeting of RAS.

Authors:  J Matthew Rhett; Imran Khan; John P O'Bryan
Journal:  Adv Cancer Res       Date:  2020-07-09       Impact factor: 6.242

Review 2.  Clinical pharmacokinetics of sulindac. A dynamic old drug.

Authors:  N M Davies; M S Watson
Journal:  Clin Pharmacokinet       Date:  1997-06       Impact factor: 6.447

3.  Sulindac sulfide selectively inhibits growth and induces apoptosis of human breast tumor cells by phosphodiesterase 5 inhibition, elevation of cyclic GMP, and activation of protein kinase G.

Authors:  Heather N Tinsley; Bernard D Gary; Adam B Keeton; Wei Zhang; Ashraf H Abadi; Robert C Reynolds; Gary A Piazza
Journal:  Mol Cancer Ther       Date:  2009-12       Impact factor: 6.261

4.  Assessment of the involvement of oxidative stress and Mitogen-Activated Protein Kinase signaling pathways in the cytotoxic effects of arsenic trioxide and its combination with sulindac or its metabolites: sulindac sulfide and sulindac sulfone on human leukemic cell lines.

Authors:  M Stępnik; M Ferlińska; A Smok-Pieniążek; D Gradecka-Meesters; J Arkusz; M Stańczyk
Journal:  Med Oncol       Date:  2011-04-27       Impact factor: 3.064

5.  A novel sulindac derivative that does not inhibit cyclooxygenases but potently inhibits colon tumor cell growth and induces apoptosis with antitumor activity.

Authors:  Gary A Piazza; Adam B Keeton; Heather N Tinsley; Bernard D Gary; Jason D Whitt; Bini Mathew; Jose Thaiparambil; Lori Coward; Gregory Gorman; Yonghe Li; Brahma Sani; Judith V Hobrath; Yulia Y Maxuitenko; Robert C Reynolds
Journal:  Cancer Prev Res (Phila)       Date:  2009-05-26

6.  Nested case-control study of the effects of non-steroidal anti-inflammatory drugs on breast cancer risk and stage.

Authors:  C R Sharpe; J P Collet; M McNutt; E Belzile; J F Boivin; J A Hanley
Journal:  Br J Cancer       Date:  2000-07       Impact factor: 7.640

7.  Breast cancer and NSAID use: a meta-analysis.

Authors:  S A Khuder; A B Mutgi
Journal:  Br J Cancer       Date:  2001-05-04       Impact factor: 7.640

Review 8.  The proapoptotic effect of traditional and novel nonsteroidal anti-inflammatory drugs in mammalian and yeast cells.

Authors:  Gianluca Farrugia; Rena Balzan
Journal:  Oxid Med Cell Longev       Date:  2013-08-01       Impact factor: 6.543

9.  COX-Independent Mechanisms of Cancer Chemoprevention by Anti-Inflammatory Drugs.

Authors:  Evrim Gurpinar; William E Grizzle; Gary A Piazza
Journal:  Front Oncol       Date:  2013-07-11       Impact factor: 6.244

Review 10.  NSAIDs: Old Drugs Reveal New Anticancer Targets.

Authors:  Gary A Piazza; Adam B Keeton; Heather N Tinsley; Jason D Whitt; Bernard D Gary; Bini Mathew; Raj Singh; William E Grizzle; Robert C Reynolds
Journal:  Pharmaceuticals (Basel)       Date:  2010-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.